Tharimmune (THAR) CFO reports no share ownership in Form 3

Rhea-AI Filing Summary

Tharimmune, Inc. executive Jacob Asbury, the company’s Chief Financial Officer, filed an initial ownership report on Form 3. The filing states that no securities of Tharimmune are beneficially owned, meaning he reported holding no company shares or derivative securities as of the reported event date.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Asbury Jacob

(Last) (First) (Middle)

10 CLIFTON TERRACE

(Street)

WEEHAWKEN NJ 07086

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/10/2025

3. Issuer Name and Ticker or Trading Symbol
Tharimmune, Inc. [ THAR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Jacob Asbury	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Tharimmune (THAR) Form 3 filing by Jacob Asbury show?

The Form 3 for Tharimmune (THAR) shows Chief Financial Officer Jacob Asbury reporting his initial ownership position. The filing states that no Tharimmune securities are beneficially owned, indicating zero reported holdings at the time of the disclosed event.

Who is the reporting person in this Tharimmune (THAR) Form 3?

The reporting person is Jacob Asbury, who serves as Chief Financial Officer of Tharimmune, Inc. The filing identifies him as an officer, not a director or 10% owner, and reports his initial beneficial ownership position in Tharimmune securities.

Does Tharimmune’s CFO beneficially own any THAR shares in this Form 3?

According to this Form 3, Tharimmune’s CFO Jacob Asbury reports that no securities are beneficially owned. Both the non-derivative and derivative tables show no holdings, meaning he reports no Tharimmune shares or derivative securities as of the event date.

What is the relationship of Jacob Asbury to Tharimmune (THAR) in this filing?

The filing identifies Jacob Asbury as an officer of Tharimmune, Inc., specifically the Chief Financial Officer. He is not listed as a director or 10% owner, and this Form 3 records his initial ownership status in that officer role.

What is the event date reported in the Tharimmune (THAR) Form 3?

The Form 3 lists an event date of 12/10/2025. This date indicates when the ownership status requiring disclosure occurred, with the filing then stating that no Tharimmune securities were beneficially owned as of that event date.